Skip to content

PRSS1 isoforms promote type 2 immune responses in IgG4-related disease

Sep 2026 · Genes and Immunity · Vol 27, pp. 566 - 571 · 0 citations · 16 references
Medicine

TL;DR

It is found that molecules produced by M2 macrophages, including TGF-β, may promote type 2 immune responses, which may contribute to the pathogenesis of IgG4-RD by activating type 2 immune responses.

View source

Similar papers

Review Oct 2026

From immune heterogeneity to targeted therapies in IgG4-related disease.

PURPOSE OF REVIEW Recent advances in single-cell, spatial, and multiomic technologies have provided new insights into the immunopathogenesis and clinical heterogeneity of IgG4-related disease (IgG4-RD). At the same time, several mechanism-based therapies have entered clinical development. RECENT FINDINGS Recent studi...

Satoshi Hara, Ichiro Mizushima, Yasunori Iwata · 0 citations
Review Oct 2026

MRGPRX2 in Allergic and Immune-Mediated Diseases: Mechanisms, Clinical Relevance, and Therapeutic Translation

Current data support MRGPRX2 as an investigational endotype-defining pathway rather than a universal driver of allergic or immune-mediated disease, and integrates these findings with receptor pharmacology and early clinical development.

W. Reinisch, Yi Li, Peng-Ju Xiong et al. · 0 citations
Open access Sep 2026

Transcriptomic and histological analyses reveal immune dysregulation in BK virus-associated nephropathy

BK virus-associated nephropathy (BKVN) is an important cause of kidney allograft failure and involves complex immune responses. This study aimed to characterize gene expression changes and immune microenvironment features in BKVN tissues using transcriptomic analysis. Using the public dataset GSE47199, we performed d...

Shuang Fei, Bo-Wen Wang, Qian-Guang Han et al. · 0 citations
Open access Oct 2026

Advancing CD38 from a marker of disease activity to an active regulator of interferon responses in juvenile dermatomyositis

Juvenile dermatomyositis (JDM), the most common pediatric inflammatory myopathy, is driven by an overactive immune signaling pathway called type I interferon. Current treatment relies on broadly immunosuppressive agents that lack mechanistic specificity, often fail to achieve durable disease control, and can result in...

Brittany A. Moser, Chioma J. Madubata, Marissa Y. Chou et al. · 0 citations
Open access Oct 2026

Clinical manifestations of patients with STAT1 gain-of-function variants in Mexico

This cohort illustrates the broad clinical spectrum of STAT1 GOF disease, including infectious, inflammatory, autoimmune, and hematological manifestations, and BCG disease and tuberculosis were observed in a subset of patients, highlighting the complexity of clinical presentation and the importance of comprehensive eva...

T. Cova-Guzmán, Satoshi Okada, M. Tsumura et al. · 0 citations
Oct 2026

Effects of Paeonia-derived Catechin on Neutrophil-associated Inflammation in Pneumonia.

Pneumonia in children is frequently accompanied by excessive inflammatory responses and immune dysregulation, which may lead to severe clinical outcomes. Catechin has shown anti-inflammatory activity in multiple disease settings, but its role and molecular mechanisms in pneumonia remain unclear. Public bulk RNA-sequenc...

Wei Bo, Jian Zhang, Nan Jiang · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.